Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mucinex D for Symptomatic Therapy in Acute Upper Respiratory Tract Infection
NCT01202279Phase 4Completed
- Sponsor
- Reckitt
- Start
- Oct 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of guaifenesin + pseudoephedrine hydrochloride in acute upper respiratory tract infection (URI), sponsored by Reckitt. Started Oct 2009; status: completed.
02
Drugs
guaifenesin + pseudoephedrine hydrochloride
03
Conditions
acute upper respiratory tract infection (URI)
Beyond the preview
Go deeper on NCT01202279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01202279.